SEC (Securities and Exchange Commission) accounting probe batters Tyco's fluctuating shares
This article was originally published in Clinica
Tyco International's shares resumed their rollercoaster ride falling to a new year low, after the company said that the US Securities and Exchange Commission (SEC) had launched an informal inquiry into its acquisition accounting practices. The US conglomerate has made over 100 acquisitions in the past six years, including its $3.3 billion purchase of US Surgical last year.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.